The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors
暂无分享,去创建一个
M. Rotondi | L. Chiovato | L. Persani | M. Muzza | M. Denegri | F. Latrofa | F. Coperchini | L. Croce | O. Awwad | S. T. Ngnitejeu | V. Capelli